title: Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders.
abstract: Functional brain imaging using 18F fluorodeoxyglucose (FDG) and positron emission tomography (PET) has greatly enhanced our understanding of brain function both in normal conditions as well as in a wide variety of neuropsychiatric disorders. We review the uses of FDG PET in the diagnosis, management, and follow-up of patients with neuropsychiatric disorders. This article will also explore what FDG-PET imaging has revealed in these neuropsychiatric disorders and how these findings relate to both research and clinical applications.
authors.affiliation: Division of Nuclear Medicine, The Hospital of the University of Pennsylvania, Philadelphia 19104, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Newberg
authors.forename: Abass
authors.initials: A
authors.lastname: Alavi
authors.forename: Martin
authors.initials: M
authors.lastname: Reivich
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000000981:diagnostic imaging* / Q000503:physiopathology; D001927:Brain Diseases / Q000000981:diagnostic imaging* / Q000503:physiopathology; D019788:Fluorodeoxyglucose F18; D006801:Humans; D001523:Mental Disorders / Q000000981:diagnostic imaging* / Q000503:physiopathology; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals
chemical_list: D001786:Blood Glucose; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18